AKT1 and nasopharyngeal carcinoma: Over-expression of EphA2 led to increased PI3K/Akt activity, resulting in promotion of cell cycle progression in NPC cells, whilst inhibition of PI3K/Akt reversed the EphA2-mediated reduction in paclitaxel sensitivity.